Deepbridge Capital

Spotlight Pathology is a company focused on developing advanced medical diagnostic tools that leverage artificial intelligence to enhance the diagnosis of blood cancers. The company’s platform integrates bioinformatics and genomics to analyze digital histopathology and multiplex immunofluorescence image data. By utilizing AI for data analysis, Spotlight Pathology aims to improve disease outcome prediction and enable healthcare professionals to detect and diagnose blood cancers at an early stage.

HeadBox is a UK-based online marketplace that connects corporate and SME event planners directly with owners of unique, inspiring, and off-site meeting spaces. Its platform enables users to search, book, and pay for spaces online, streamlining the event planning process. HeadBox caters to a wide range of events, including workshops, meetings, product launches, and corporate parties, helping both guests and hosts unlock revenue and reduce hassle. Founded in 2015, the company is headquartered in Reading, United Kingdom.

AI-Sight is a startup that is developing an AI diabetic retinal screening system to deliver WHO-recommended diabetic eye screening services.

Microplate Dx is a developer of innovative diagnostic technology aimed at addressing the critical global health issue of antimicrobial resistance, which leads to drug-resistant infections. Originating as a spinout from the University of Strathclyde in Glasgow, the company focuses on creating solutions that significantly reduce fatalities associated with these infections. Its core technology utilizes highly sensitive biosensor electrodes paired with miniaturized hydrogel deposits containing antibiotics specifically designed for the infections being tested. This approach offers a low-cost, accurate point-of-care diagnostic device that enables timely and optimal antibiotic prescribing, allowing healthcare providers to deliver effective treatments in under one hour. Microplate Dx's mission is to enhance antibiotic stewardship and proactively combat the rise of antimicrobial resistance worldwide.

Thalia Design Automation Ltd., established in 2011 with headquarters in Bath, United Kingdom, and an engineering center in Hyderabad, India, specializes in semiconductor electronic design automation (EDA). The company offers software solutions tailored for the design of analog and mixed-signal integrated circuits. Their flagship products include AMALIA, a toolset for optimizing analog circuits using CAD/EDA methodologies and mathematical modeling, and EMERA, a finite element parametrisable power device design and optimization toolset. Additionally, Thalia provides custom power device development as an IP service and offers SaaS-based solutions for onsite or cloud-based access to their tools. The company also supports analog circuit porting services, enabling efficient migration and optimization of existing designs for new technologies and applications.

IbisVision Limited is a company that specializes in developing visual field test software aimed at the early detection of glaucoma, a leading cause of blindness. Its flagship product, Ring of Sight, utilizes patented technology to offer a unique eye testing experience through a cloud-based application that can be accessed remotely from various locations. The software consolidates multiple eye tests into one device, allowing healthcare professionals to conduct both in-practice and no-contact testing. This innovative approach not only enhances patient care but also supports optometrists in maximizing operational efficiency. Founded in 2013 and located in Livingston, United Kingdom, IbisVision is committed to improving eye care by providing a reliable and secure platform for diagnosing and monitoring glaucoma. The application ensures data privacy through secure encrypted servers, underscoring the company's dedication to maintaining high standards of patient confidentiality and security.

GenoME Diagnostics is a biotechnology company focused on developing innovative blood tests aimed at improving cancer detection and diagnosis. The company has created the OvaME product, which enhances the traditional CA125 blood tests, offering a more accurate and earlier detection of various cancers. By employing advanced techniques, GenoME Diagnostics aims to minimize misdiagnosis and late detection, enabling healthcare professionals to diagnose and treat patients more effectively. This commitment to developing life-saving diagnostic tools positions the company as a significant player in the field of oncology diagnostics.

Circada's unique lighting controls improve health and well-being. This consists of an adapter that connects to existing tuneable white LED drivers and is simple to retrofit without the need for complex commissioning, with a standard light switch serving as its interface. We can provide additional configuration prior to installation if necessary for a specific project in order to match the lighting specification, once again providing advanced circadian lighting that is plug-and-play and commission free.

Touch Biometrix Ltd is a company founded in 2017 and based in Conwy, United Kingdom, specializing in the design and development of fingerprint authentication sensors for the consumer electronics sector. The company focuses on creating a new fingerprint authentication platform that utilizes advanced sensing technology and innovative manufacturing models. This enables the production of high-performance fingerprint sensors that can be integrated seamlessly into a wide variety of devices, regardless of shape or size. Touch Biometrix aims to enhance user experience by providing secure and convenient identity authentication solutions, effectively eliminating the reliance on traditional passwords. Their technology is designed to facilitate easy integration into both flat and curved surfaces, making it suitable for a broad range of applications in the growing market of smart devices.

FluoretiQ Limited is a medical device company based in Bristol, United Kingdom, established in 2017. The company specializes in developing innovative technologies for the rapid detection of bacterial infections. FluoretiQ's proprietary solutions integrate advanced nanomaterials and optical sensing technologies, allowing for the identification of harmful bacteria in as little as 15 minutes. Their flagship product, the NANOPLEXa, is a rapid diagnostic platform that enables healthcare professionals to accurately identify and enumerate bacterial pathogens, facilitating timely and effective antibiotic treatment. By providing easy-to-use systems, FluoretiQ empowers clinicians to make informed decisions for same-day diagnosis and appropriate antibiotic selection, ultimately enhancing patient care in the management of infectious diseases.

Pathfinder Medical is focused on developing an innovative electronic guidance system that allows clinicians to connect blood vessels through minimally invasive techniques. This novel catheter-based technology is specifically designed for vascular access creation, addressing critical needs in the treatment of kidney failure, particularly for patients requiring hemodialysis. The system is engineered to be performed outside of the operating room, reducing the likelihood of complications and enhancing patient care. Pathfinder Medical's platform has significant potential across various clinical applications, including bypassing peripheral blockages, and operates within a substantial market valued at £1.6 billion annually.

Aegiq Ltd. is a company specializing in the development of semiconductor-based quantum photonic chips, which are designed for various communications and computing applications such as broadband quantum communication, imaging, microscopy, and scalable quantum computing. Founded in 2019 and headquartered in Sheffield, United Kingdom, Aegiq adopts a full-stack photonic quantum computing approach that provides speed, compactness, and modularity. The company's technology serves a diverse range of industries, including defense, aerospace, cybersecurity, and artificial intelligence, addressing complex computational challenges. Aegiq's integrated photonic platform aims to facilitate large-scale quantum computing with multi-million qubit operations, offering a comprehensive portfolio of products and systems related to quantum cybersecurity and networking.

Glucose Republic is a company focused on improving metabolic health through biology-influenced software. It has developed a personalized nutrition application that provides users with tools to better understand their metabolic intake and responses. The software allows individuals to measure and predict how various foods and exercise impact their metabolism, thereby empowering them to make informed decisions about their diet and lifestyle. By offering a personalized intelligence system, Glucose Republic aims to help users optimize their health and well-being.

Glyconics Ltd. is a diagnostics company based in Cambridge, United Kingdom, that specializes in developing portable infrared spectroscopy devices for the diagnosis and monitoring of chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Founded in 2013, Glyconics has created a hand-held miniaturized device that allows patients to conduct tests at home by analyzing sputum samples for specific biomarkers associated with COPD. Utilizing Fourier transform infrared spectroscopy, the device identifies spectral waves to provide detailed insights into the composition of the samples, facilitating early detection and monitoring of exacerbations in patients with suspected respiratory diseases.

SmallSpark is a Welsh aerospace company based in Cardiff Bay, focused on developing hybrid engine launch vehicle technology. The company aims to significantly reduce the cost of access to space, making it feasible for a wide range of clients to send payloads into orbit or on sounding rockets. By offering low-cost space vehicles, SmallSpark enables customers to utilize advanced hybrid rocket motor technology, thereby democratizing access to space and fostering broader commercial opportunities in the aerospace sector.

HeadBox is a UK-based online marketplace that connects corporate and SME event planners directly with owners of unique, inspiring, and off-site meeting spaces. Its platform enables users to search, book, and pay for spaces online, streamlining the event planning process. HeadBox caters to a wide range of events, including workshops, meetings, product launches, and corporate parties, helping both guests and hosts unlock revenue and reduce hassle. Founded in 2015, the company is headquartered in Reading, United Kingdom.

Ferryx is a biotechnology company focused on developing live biotherapeutics to address gut inflammation, particularly in conditions such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). IBD affects approximately 6.8 million individuals globally, highlighting the urgent need for effective treatments. Ferryx creates safe and effective bacterial products aimed at preventing and treating gastrointestinal inflammation. The company's innovative approach offers the medical community and patients natural alternatives to conventional medications, which often come with adverse side effects. By prioritizing the development of these biotherapeutics, Ferryx seeks to improve the quality of life for those suffering from debilitating gut conditions.

GenoME Diagnostics is a biotechnology company focused on developing innovative blood tests aimed at improving cancer detection and diagnosis. The company has created the OvaME product, which enhances the traditional CA125 blood tests, offering a more accurate and earlier detection of various cancers. By employing advanced techniques, GenoME Diagnostics aims to minimize misdiagnosis and late detection, enabling healthcare professionals to diagnose and treat patients more effectively. This commitment to developing life-saving diagnostic tools positions the company as a significant player in the field of oncology diagnostics.

Viscgo Limited is a company that specializes in the design, development, and delivery of innovative devices and technologies aimed at improving the management of dysphagia, a swallowing disorder. Founded in 2015 and based in Warrington, United Kingdom, Viscgo's product offerings include drink thickness testers that measure the viscosity of various drinks and textured-modified foods. Their technology enables caregivers and healthcare professionals in hospitals, care homes, schools, and nurseries to provide smooth fluids to patients with dysphagia, thereby enhancing their care and quality of life.

Filisia Interfaces Ltd. specializes in developing multimedia and multisensory devices aimed at enhancing training and rehabilitation for individuals with special education and rehabilitation needs. Founded in 2014 and based in London, the company offers Monoma, a training system designed for people with learning and physical disabilities. Filisia’s solutions leverage creative technology, integrating music and games to engage users in physical, cognitive, and communication skill development. The company's software features gamified rehabilitation exercises tailored to various conditions, with multiple difficulty levels to assess and improve user capabilities. Additionally, it provides valuable data analytics to track progress in physical and cognitive skills, addressing the challenges of traditional rehabilitation methods, which can be costly and monotonous. By focusing on innovative, engaging training solutions, Filisia aims to optimize therapy outcomes and reduce care costs for the estimated 150 million individuals worldwide with special education and rehabilitation needs.

VoxSmart Limited is a telecommunications software provider based in London, specializing in solutions for financial services companies both in the United Kingdom and internationally. Founded in 2006, the company offers VSMART, a comprehensive software solution designed to capture, record, store, transcribe, and analyze employee communications, including mobile calls, messages, and voicemails across various devices and networks. VoxSmart's technology enables firms to manage business risk and comply with regulatory requirements by transforming captured data into actionable insights regarding employee conduct and operational efficiency. With a team of experts in finance, regulation, and business analytics, VoxSmart aims to enhance clients' decision-making processes and improve their overall business operations. The company has also formed a strategic alliance with Eventus Systems, Inc. to further strengthen its offerings.

We help Startups with their digital products.

Carocell Bio is a biotechnology company focused on developing innovative treatments for serious inflammatory disorders. The company aims to provide safer and more effective solutions for conditions such as atopic dermatitis, inflammatory bowel disease, and burns. Their approach utilizes human biopsy samples to enhance the management of these disorders, particularly in preventing scarring after surgical procedures or burns. By prioritizing the development of groundbreaking therapies, Carocell Bio seeks to lead in its field and achieve revenue generation within five years through potential out-licensing or trade sales of its primary projects.

Circada's unique lighting controls improve health and well-being. This consists of an adapter that connects to existing tuneable white LED drivers and is simple to retrofit without the need for complex commissioning, with a standard light switch serving as its interface. We can provide additional configuration prior to installation if necessary for a specific project in order to match the lighting specification, once again providing advanced circadian lighting that is plug-and-play and commission free.

NanOptima is a company focused on advancing the treatment of retinal diseases through innovative ophthalmic drug delivery technology. By developing controlled-release drug depots, NanOptima aims to significantly reduce the frequency of intraocular injections for patients, proposing a solution that allows for treatment twice a year instead of the conventional approach. The company's technology not only enhances the delivery of medications for conditions like wet age-related macular degeneration but also includes capabilities for detecting various eye diseases and disorders. This approach seeks to maintain constant intraocular medication concentrations, thereby improving patient outcomes and minimizing the risk of incomplete treatments.

LogChain is a digital platform dedicated to transforming supply chain management for businesses of all sizes, using advanced technology to enhance efficiency, security, and compliance. By incorporating blockchain technology, LogChain captures data and documentation throughout the entire trade process, particularly benefiting chemical manufacturers and shippers. This innovative approach allows clients to optimize their logistics workflows, including customs clearance, while reducing costs, time, and risk associated with shipments. LogChain's platform is designed for seamless integration with existing systems and supports a wide range of businesses, from micro-enterprises to multinational corporations. With a strong focus on transparency and security, LogChain empowers organizations to streamline their operations and improve customer service, marking a significant advancement in supply chain management.

SmallSpark is a Welsh aerospace company based in Cardiff Bay, focused on developing hybrid engine launch vehicle technology. The company aims to significantly reduce the cost of access to space, making it feasible for a wide range of clients to send payloads into orbit or on sounding rockets. By offering low-cost space vehicles, SmallSpark enables customers to utilize advanced hybrid rocket motor technology, thereby democratizing access to space and fostering broader commercial opportunities in the aerospace sector.

Circada's unique lighting controls improve health and well-being. This consists of an adapter that connects to existing tuneable white LED drivers and is simple to retrofit without the need for complex commissioning, with a standard light switch serving as its interface. We can provide additional configuration prior to installation if necessary for a specific project in order to match the lighting specification, once again providing advanced circadian lighting that is plug-and-play and commission free.

Liverpool ChiroChem Limited, established in 2014, is a UK-based company specializing in the production of chiral small molecules for biotech and pharmaceutical research and development. It offers a range of products, including 3D heterocyclic and carbocyclic API and intermediates, custom synthesis services, building blocks for DNA-encoded library synthesis, and fragment libraries. These products serve as essential building blocks, fragments, and screening compounds, facilitating small molecule drug discovery. The company's expertise lies in asymmetric hydrogenation and Pd-coupling technologies, enabling efficient access to novel chiral building blocks and a wide range of chiral amines with excellent enantiomeric purity. Liverpool ChiroChem's initial focus is on the production and supply of chiral piperidines and other sp3-rich nitrogen heterocycles, which are crucial in drug discovery due to their favorable pharmacokinetic properties. The company collaborates with customers to optimize synthetic routes, providing tailored solutions to meet their specific research needs.

Blossom Genetics produces proprietary medicinal cannabis genetics and products. Our mission is to advance medicinal cannabis through scientific research to develop best in class products for our customers.

Elasmogen Ltd is a biopharmaceutical company based in Aberdeen, United Kingdom, founded in 2014. The company specializes in discovering and developing novel therapies for inflammatory eye diseases and other autoimmune conditions. Elasmogen's primary innovation lies in its proprietary soloMER technology, which consists of small, stable proteins derived from variable new-antigen receptors (VNARs) found in sharks. These next-generation therapeutics are designed to be significantly smaller and more robust than traditional antibodies while avoiding complex patent landscapes. Elasmogen's pipeline includes various candidates targeting autoimmune-mediated inflammatory diseases, such as ELN/21 and ELN/22, as well as soloMER-drug conjugates and NDure, which enhances the plasma half-life of therapeutic molecules. The company has established strategic partnerships with Almac Discovery Ltd and Merck Inc., and it possesses a comprehensive intellectual property portfolio that includes exclusive licenses for over 20 patents across multiple jurisdictions.

Ostara Biomedical Ltd. is a biotechnology company based in Liverpool, United Kingdom, focused on developing innovative technologies for artificial reproduction across various mammalian species. Established in 2012, the company specializes in enhancing the success rates of assisted reproduction in diverse settings, including domestic livestock and laboratory rodents. Ostara's ProgenySys™ product suite features a novel vaginal pessary system designed to induce pseudopregnancy in female mice prior to embryo transfers. This approach not only aims to improve reproductive outcomes but also offers significant cost savings and addresses ethical concerns by reducing the number of animals required in breeding programs. Through its advancements in fertility technologies, Ostara Biomedical supports individuals and healthcare providers in navigating the fertility pathway, from diagnosis to conception and birth.

Thalia Design Automation Ltd., established in 2011 with headquarters in Bath, United Kingdom, and an engineering center in Hyderabad, India, specializes in semiconductor electronic design automation (EDA). The company offers software solutions tailored for the design of analog and mixed-signal integrated circuits. Their flagship products include AMALIA, a toolset for optimizing analog circuits using CAD/EDA methodologies and mathematical modeling, and EMERA, a finite element parametrisable power device design and optimization toolset. Additionally, Thalia provides custom power device development as an IP service and offers SaaS-based solutions for onsite or cloud-based access to their tools. The company also supports analog circuit porting services, enabling efficient migration and optimization of existing designs for new technologies and applications.

BackHug, developed by Pacla Medical, is an innovative company that offers a robotic spine massage device designed to alleviate back pain and improve flexibility. Utilizing patented technology, BackHug employs 26 robotic fingers to apply deep tissue pressure to the back and shoulder blades, resulting in an average reduction of back pain by 51%. The accompanying BackHug App allows users to customize their treatment plans through an in-app consultation and monitor changes in back relaxation levels. This data is analyzed using artificial intelligence to further optimize individual treatments. BackHug has garnered a growing customer base, who report significant satisfaction and cost savings compared to traditional therapies. With a team of approximately 16 employees based in the UK and Vietnam, the company aims to transform the lives of over 197 million individuals suffering from back pain, neck pain, and related conditions.

Filisia Interfaces Ltd. specializes in developing multimedia and multisensory devices aimed at enhancing training and rehabilitation for individuals with special education and rehabilitation needs. Founded in 2014 and based in London, the company offers Monoma, a training system designed for people with learning and physical disabilities. Filisia’s solutions leverage creative technology, integrating music and games to engage users in physical, cognitive, and communication skill development. The company's software features gamified rehabilitation exercises tailored to various conditions, with multiple difficulty levels to assess and improve user capabilities. Additionally, it provides valuable data analytics to track progress in physical and cognitive skills, addressing the challenges of traditional rehabilitation methods, which can be costly and monotonous. By focusing on innovative, engaging training solutions, Filisia aims to optimize therapy outcomes and reduce care costs for the estimated 150 million individuals worldwide with special education and rehabilitation needs.

Touch Biometrix Ltd is a company founded in 2017 and based in Conwy, United Kingdom, specializing in the design and development of fingerprint authentication sensors for the consumer electronics sector. The company focuses on creating a new fingerprint authentication platform that utilizes advanced sensing technology and innovative manufacturing models. This enables the production of high-performance fingerprint sensors that can be integrated seamlessly into a wide variety of devices, regardless of shape or size. Touch Biometrix aims to enhance user experience by providing secure and convenient identity authentication solutions, effectively eliminating the reliance on traditional passwords. Their technology is designed to facilitate easy integration into both flat and curved surfaces, making it suitable for a broad range of applications in the growing market of smart devices.

As featured on the BBC, TimeOut London, Evening Standard, and Conde Nast Traveler. TubeChat is the only free to download iPhone group messaging app that works on the London Underground where there is no cellular or wifi. TubeChat uses Bluetooth on your iPhone to make automatic incognito connections to people with the same app up to 200 meters away allowing you to chat and play underground. What can you do on TubeChat? LINK - UP: Make new friends. TubeChat facilitates real-life conversations and meetings in areas where other popular social networking or dating apps just don’t work. CHAT: Group chat safely completely ad-free with up to 10 other users nearby. We don’t reveal your identity unless you want to. Maintain your mystery by not updating your profile picture. PLAY: With TubeChat you will be able to play classic games such as I Spy. Have you got a favourite game you’d like to see in the app? Let us know and we’ll see what we can do.

Compono is a software company that specializes in intelligent hiring solutions aimed at enhancing recruitment processes. The company develops a platform that utilizes data, science, and technology to optimize the hiring, development, and engagement of employees. By employing a unique algorithm, Compono's software matches candidates to specific job requirements, actively comparing and contrasting their skills and qualifications. This approach allows recruiters to rank candidates according to their suitability for roles, ultimately facilitating better organizational design and improving workforce productivity. Through its innovative solutions, Compono strives to unlock the potential of both individuals and organizations in the hiring landscape.

Keia is an online platform designed to connect practitioners and consumers of wellness services across 27 different areas, including acupuncture, massage, physiotherapy, relationship counseling, and yoga. The company's mission is to make wellness services accessible and affordable for all individuals. By leveraging technology, Keia provides healthcare professionals with a comprehensive suite of cloud-based business management software, simplifying the processes of managing and growing their practices. This platform enables patients to easily locate wellness practitioners in their local areas, thus enhancing the accessibility of various wellness therapies.

Jammtoday is a UK-based company that operates an online platform designed to help users compare and select robo-advisors and passive investment providers. The platform allows users to input their investment objectives and needs, filtering providers based on these criteria. Jammtoday then provides direct links to the chosen provider's website, enabling users to complete their investment journey seamlessly. The company aims to address the 'advice gap' by offering a user-friendly tool for comparing low-cost investment options, catering to both casual savers and experienced investors.

Mynurva is a company focused on enhancing accessibility to high-quality behavioral health services in the UK through the use of technology. It has developed an online therapy platform that facilitates counseling sessions via live video chats with expert therapists. This approach allows patients to receive reliable and discreet mental health support from the comfort of their own homes, ensuring that such services are available to everyone, regardless of location. Mynurva's mission is to transform the provision of behavioral health services, making them more accessible and effective for those in need.

Chainvine Ltd, established in 2015 and headquartered in Ipswich, UK, specializes in developing bespoke blockchain-based platforms for identity, asset, and encryption management. Its distributed ledger technology (DLT) decentralizes data across a network of nodes, providing secure, permanent cloud storage for transactional data. Chainvine's key products include Intelligent Commodities, which facilitates tracking and recording of physical commodities and supply chain data when integrated with IoT partners, and Intelligent Contracts, enabling businesses to manage digital contracts and store data changes. The company supports multiple blockchain technologies and offers enterprise-grade security, increasing businesses' financial margins and accountability.

Touch Biometrix Ltd is a company founded in 2017 and based in Conwy, United Kingdom, specializing in the design and development of fingerprint authentication sensors for the consumer electronics sector. The company focuses on creating a new fingerprint authentication platform that utilizes advanced sensing technology and innovative manufacturing models. This enables the production of high-performance fingerprint sensors that can be integrated seamlessly into a wide variety of devices, regardless of shape or size. Touch Biometrix aims to enhance user experience by providing secure and convenient identity authentication solutions, effectively eliminating the reliance on traditional passwords. Their technology is designed to facilitate easy integration into both flat and curved surfaces, making it suitable for a broad range of applications in the growing market of smart devices.

vTime is a virtual reality software company specializing in the development of apps and cloud-based solutions that enhance virtual engagement and communication. It operates a consumer social VR app, vTime, which has gained significant traction since its launch in December 2015, connecting hundreds of thousands of users globally. The platform serves as a virtual reality social network, offering immersive experiences that enable users to engage with others in virtual locations, fostering real human connections. vTime's innovative approach allows users to chat, share media, and spend quality time with friends and family, positioning the company as a leader in the rapidly growing virtual reality sector in Europe.

Liverpool ChiroChem Limited, established in 2014, is a UK-based company specializing in the production of chiral small molecules for biotech and pharmaceutical research and development. It offers a range of products, including 3D heterocyclic and carbocyclic API and intermediates, custom synthesis services, building blocks for DNA-encoded library synthesis, and fragment libraries. These products serve as essential building blocks, fragments, and screening compounds, facilitating small molecule drug discovery. The company's expertise lies in asymmetric hydrogenation and Pd-coupling technologies, enabling efficient access to novel chiral building blocks and a wide range of chiral amines with excellent enantiomeric purity. Liverpool ChiroChem's initial focus is on the production and supply of chiral piperidines and other sp3-rich nitrogen heterocycles, which are crucial in drug discovery due to their favorable pharmacokinetic properties. The company collaborates with customers to optimize synthetic routes, providing tailored solutions to meet their specific research needs.

Renephra Ltd., established in 2009 and headquartered in Manchester, UK, is a medical device company specializing in controlled fluid removal from the skin. Its core product employs Transdermal Fluid Removal (TFR) technology, combining micro-needles with negative pressure therapy to enable minimally invasive extraction of excess interstitial fluid. Renephra targets fluid overload and chronic oedema/lymphoedema in vascular, oncology, and other disease areas, addressing significant unmet clinical needs in an estimated £1 billion global market.

Zilico Limited is a medical diagnostics company focused on developing innovative devices for cancer detection, particularly cervical cancer. Founded in 2006 and based in Manchester, United Kingdom, with an additional office in Sheffield, Zilico utilizes electrical impedance spectroscopy technology to enhance diagnostic accuracy and provide real-time results. Its primary product, ZedScan, is designed to assess cervical epithelial tissue objectively during colposcopy, thereby reducing the subjectivity associated with traditional diagnostic methods. The company is advancing its offerings with two applications aimed at improving referral and screening processes for neoplastic conditions. By enhancing the ability to detect cervical intraepithelial neoplasia, Zilico aims to support healthcare professionals in delivering better diagnostic accuracy and optimizing cancer screening programs.

Keia is an online platform designed to connect practitioners and consumers of wellness services across 27 different areas, including acupuncture, massage, physiotherapy, relationship counseling, and yoga. The company's mission is to make wellness services accessible and affordable for all individuals. By leveraging technology, Keia provides healthcare professionals with a comprehensive suite of cloud-based business management software, simplifying the processes of managing and growing their practices. This platform enables patients to easily locate wellness practitioners in their local areas, thus enhancing the accessibility of various wellness therapies.

Hurricane Modular Commerce Limited, established in 2016 and located in Saint Albans, United Kingdom, specializes in providing a compliant landed cost engine designed for the logistics and transport sectors. The company leverages over a century of combined expertise in logistics, transport, and information technology to offer tailored solutions for businesses. Its services include a flexible pricing structure that aids clients in budgeting for tax and import duty calculations, ensuring transparency and accuracy in their financial planning. By bringing together specialists in various fields, Hurricane Modular Commerce delivers innovative and adaptable solutions to meet the evolving needs of its customers.

Cell Lane Ltd has been established to develop a cell isolation and separation platform technology, based on intellectual property assigned from the University of Leeds. This new technology seeks to assist in the future treatment of chronic diseases such as cancer and AIDS, and is intended to enable new fields of research in research activities such stem cell research. The Company’s proposed technology can be used to rapidly separate cells whilst preserving their functionality and overall viability. Cell Lane is in the process of developing its technology to a point where it has a Minimum Viable Product (‘MVP’), the MVP (i.e. the new platform) will then be developed and taken forwards to be commercialised by the Company.

BackHug, developed by Pacla Medical, is an innovative company that offers a robotic spine massage device designed to alleviate back pain and improve flexibility. Utilizing patented technology, BackHug employs 26 robotic fingers to apply deep tissue pressure to the back and shoulder blades, resulting in an average reduction of back pain by 51%. The accompanying BackHug App allows users to customize their treatment plans through an in-app consultation and monitor changes in back relaxation levels. This data is analyzed using artificial intelligence to further optimize individual treatments. BackHug has garnered a growing customer base, who report significant satisfaction and cost savings compared to traditional therapies. With a team of approximately 16 employees based in the UK and Vietnam, the company aims to transform the lives of over 197 million individuals suffering from back pain, neck pain, and related conditions.

Sky Medical Technology Limited is a biomedical device company based in High Wycombe, United Kingdom, specializing in neuromuscular electro-stimulation medical devices. Founded in 2006, the company has developed innovative products such as the geko device, which stimulates the common peroneal nerve to enhance venous blood flow, and the firefly device, designed to aid professional athletes in muscle recovery by improving lower limb circulation. The company’s OnPulse™ technology represents a significant advancement in bioelectronic compression therapy, offering clinically proven solutions for preventing and treating various circulatory conditions, including life-threatening blood clots, post-surgical swelling, and non-healing wounds. Sky Medical Technology's products cater to a range of medical applications and are utilized by healthcare professionals, including surgeons, nurses, physiotherapists, and podiatrists, in both clinical practice and studies. The company distributes its devices internationally across multiple regions, including Asia, Europe, and North America.

Pathfinder Medical is focused on developing an innovative electronic guidance system that allows clinicians to connect blood vessels through minimally invasive techniques. This novel catheter-based technology is specifically designed for vascular access creation, addressing critical needs in the treatment of kidney failure, particularly for patients requiring hemodialysis. The system is engineered to be performed outside of the operating room, reducing the likelihood of complications and enhancing patient care. Pathfinder Medical's platform has significant potential across various clinical applications, including bypassing peripheral blockages, and operates within a substantial market valued at £1.6 billion annually.

Tookie Limited, established in 2015 and based in Liverpool, UK, specializes in developing and selling innovative medical vests designed specifically for children undergoing chemotherapy. Their flagship product, the Tookie Vest for Oncology, securely holds central venous catheters in place, reducing the risk of infection and enhancing patient comfort and mobility during long-term medical treatments.

DynamX Medical is a healthcare technology company that has created an innovative precancer screening system designed for rapid tissue biopsy analysis. This system is user-friendly and can be operated at the point of care by nurses, enhancing accessibility and efficiency in medical settings. The company's software aims to streamline disease diagnosis by increasing the speed and reliability of detection, thereby alleviating the workload on healthcare institutions. Through its novel technology, DynamX Medical seeks to improve diagnostic processes, ultimately supporting better patient outcomes and reducing the strain on healthcare resources.

BackHug, developed by Pacla Medical, is an innovative company that offers a robotic spine massage device designed to alleviate back pain and improve flexibility. Utilizing patented technology, BackHug employs 26 robotic fingers to apply deep tissue pressure to the back and shoulder blades, resulting in an average reduction of back pain by 51%. The accompanying BackHug App allows users to customize their treatment plans through an in-app consultation and monitor changes in back relaxation levels. This data is analyzed using artificial intelligence to further optimize individual treatments. BackHug has garnered a growing customer base, who report significant satisfaction and cost savings compared to traditional therapies. With a team of approximately 16 employees based in the UK and Vietnam, the company aims to transform the lives of over 197 million individuals suffering from back pain, neck pain, and related conditions.

T-EDTA Limited was established to develop anti-biofilm technologies and infection control products. Anti-biofilm is used in advanced wound care products using the anti-biofilm agents tri sodium/tetra sodium EDTA (‘t-EDTA’). A biofilm is a group of microorganisms in which cells stick to each other and often adhere to a surface, such as wound. As such, they represent a major risk of woundsite infection. EDTA is a chemical which can inhibit the development of such biofilms. Biofilms are a major problem for human infections and medical device related infections due to their becoming resistant to antibiotics, with the result being wounds that are slow to heal, or not healing/remaining open. The patented tri and tetrasodium EDTA (‘T-EDTA’) can be used to prevent and control infection in three specific areas; advanced wound care, catheters and consumer wellness (Skin/foot fungal infections).

Levitex Foams Ltd is a healthcare-focused manufacturer specializing in therapeutic mattresses designed to address poor body alignment and posture, particularly for bed-bound individuals. Their flagship product, Levitex foam, is a Class 1 medical device that helps prevent pressure sores and sleep deprivation by promoting proper postural management. The company's offerings include pillows, toppers, and mattresses, catering to patients with complex neurological illnesses or injuries such as Multiple Sclerosis, Cerebral Palsy, Motor Neurone Disease, stroke, and hypoxic brain injury. Levitex Foams Ltd supplies its products to the NHS, demonstrating its commitment to improving patient care within the UK's healthcare system.

Keia is an online platform designed to connect practitioners and consumers of wellness services across 27 different areas, including acupuncture, massage, physiotherapy, relationship counseling, and yoga. The company's mission is to make wellness services accessible and affordable for all individuals. By leveraging technology, Keia provides healthcare professionals with a comprehensive suite of cloud-based business management software, simplifying the processes of managing and growing their practices. This platform enables patients to easily locate wellness practitioners in their local areas, thus enhancing the accessibility of various wellness therapies.

Elasmogen Ltd is a biopharmaceutical company based in Aberdeen, United Kingdom, founded in 2014. The company specializes in discovering and developing novel therapies for inflammatory eye diseases and other autoimmune conditions. Elasmogen's primary innovation lies in its proprietary soloMER technology, which consists of small, stable proteins derived from variable new-antigen receptors (VNARs) found in sharks. These next-generation therapeutics are designed to be significantly smaller and more robust than traditional antibodies while avoiding complex patent landscapes. Elasmogen's pipeline includes various candidates targeting autoimmune-mediated inflammatory diseases, such as ELN/21 and ELN/22, as well as soloMER-drug conjugates and NDure, which enhances the plasma half-life of therapeutic molecules. The company has established strategic partnerships with Almac Discovery Ltd and Merck Inc., and it possesses a comprehensive intellectual property portfolio that includes exclusive licenses for over 20 patents across multiple jurisdictions.

SurveyMe is a mobile application that facilitates real-time customer feedback, known as 'Point of Experience' feedback. It offers a user-friendly platform for businesses to gather immediate insights, enabling them to make informed decisions and drive growth. The application rewards users for their feedback, incentivizing participation and ensuring a continuous flow of valuable data. SurveyMe then converts this feedback into easy-to-understand management information, providing businesses with actionable insights within seconds.

VoxSmart Limited is a telecommunications software provider based in London, specializing in solutions for financial services companies both in the United Kingdom and internationally. Founded in 2006, the company offers VSMART, a comprehensive software solution designed to capture, record, store, transcribe, and analyze employee communications, including mobile calls, messages, and voicemails across various devices and networks. VoxSmart's technology enables firms to manage business risk and comply with regulatory requirements by transforming captured data into actionable insights regarding employee conduct and operational efficiency. With a team of experts in finance, regulation, and business analytics, VoxSmart aims to enhance clients' decision-making processes and improve their overall business operations. The company has also formed a strategic alliance with Eventus Systems, Inc. to further strengthen its offerings.

EligoChem Ltd, founded in 2012 and based in Sandwich, United Kingdom, specializes in designing and developing amphiphilic compound libraries for drug discovery. The company offers drug-like compounds for screening and provides medicinal and computational chemistry support for lead optimization. EligoChem's proprietary technology focuses on creating highly water-soluble drugs that are well-absorbed by the human body, a rare combination of properties found in only one in fifteen known drug compounds. This technology is particularly valuable in antibiotic drug discovery, where it addresses the scarcity of such compounds in current pharmaceutical screening collections. Additionally, EligoChem offers consultancy services in medicinal and computational chemistry, safer drugs by design, and antibiotic drug design.

RealSpace is a cloud-based software empowering real estate professionals to effectively manage all aspects of running their business online. Real Space Limited has developed a novel, wide field-of-view multi-purpose synoptic virtual reality viewer called ‘SingleReality’, to exploit what the founders perceive as a gap in the growing VR market for a completely new headset design that offers a best-in-class user experience and is also significantly cheaper than other current available market offerings. The Company’s strategy is to offer a superior VR experience by delivering identical images to each eye from a single 2D, high resolution image. This synoptic approach is a novel addition to the VR Head-Mounted Display device market.

Viscgo Limited is a company that specializes in the design, development, and delivery of innovative devices and technologies aimed at improving the management of dysphagia, a swallowing disorder. Founded in 2015 and based in Warrington, United Kingdom, Viscgo's product offerings include drink thickness testers that measure the viscosity of various drinks and textured-modified foods. Their technology enables caregivers and healthcare professionals in hospitals, care homes, schools, and nurseries to provide smooth fluids to patients with dysphagia, thereby enhancing their care and quality of life.

Parkure Ltd is a drug discovery company focused on developing treatments for Parkinson's disease. Founded in 2014 and based in Edinburgh, United Kingdom, Parkure employs an innovative in-vivo drug discovery platform that utilizes living tissues for drug testing, which reduces the risks associated with later-stage drug development. By incorporating unique methodologies such as using fruit flies for drug screening and repurposing existing drugs, Parkure aims to advance the search for effective therapies to halt nerve cell degeneration related to Parkinson's disease. Through its research and development efforts, the company is dedicated to finding a viable cure for this challenging neurological disorder.

Transcriptogen Ltd. is a biotechnology company based in Bath, United Kingdom, focused on discovering novel transcription factor inhibitors for oncology treatments. Established in 2013, the company specializes in developing inhibitors targeting transcription factors such as NF-κB, STAT3, HIF1, and AP1, which play crucial roles in cancer cell growth. Its lead compound, TSG1301, is a potent DNA-interactive inhibitor of NF-κB, demonstrating effectiveness against breast and pancreatic cancers in preclinical models while showing low toxicity, suggesting the potential for side-effect-free therapies. Transcriptogen also offers a comprehensive drug discovery platform designed to identify additional transcription factor inhibitors for future clinical development. Furthermore, the company develops pharmacogenomics assays that help select patients with dysregulated transcription factor signaling pathways for appropriate clinical trials and treatments, aligning with the growing interest in using small molecules to inhibit disease-related gene transcription.

PeptiGelDesign Ltd. is a company based in Alderley Edge, United Kingdom, that specializes in the development and commercialization of self-assembling peptide-based hydrogels. These hydrogels are designed to create defined three-dimensional microenvironments for various cell culture applications within the life sciences sector. Additionally, the company offers cardiovascular medical devices, including a biocompatible and biodegradable cardiac patch aimed at providing mechanical support to the infarcted myocardium. PeptiGelDesign also provides design services and its products come in the form of ready-to-use, easy-to-handle hydrogels suitable for culture dishes, multi-well plates, and cell culture inserts, facilitating both two-dimensional and three-dimensional cell culture processes. The company was incorporated in 2013.

Filisia Interfaces Ltd. specializes in developing multimedia and multisensory devices aimed at enhancing training and rehabilitation for individuals with special education and rehabilitation needs. Founded in 2014 and based in London, the company offers Monoma, a training system designed for people with learning and physical disabilities. Filisia’s solutions leverage creative technology, integrating music and games to engage users in physical, cognitive, and communication skill development. The company's software features gamified rehabilitation exercises tailored to various conditions, with multiple difficulty levels to assess and improve user capabilities. Additionally, it provides valuable data analytics to track progress in physical and cognitive skills, addressing the challenges of traditional rehabilitation methods, which can be costly and monotonous. By focusing on innovative, engaging training solutions, Filisia aims to optimize therapy outcomes and reduce care costs for the estimated 150 million individuals worldwide with special education and rehabilitation needs.

Funnel Music is an innovative company focused on transforming the creation and marketing of new music. It operates an online platform that fosters a collaborative community for artists and industry professionals, allowing them to connect and engage in various music projects. By leveraging a shared outcome agreement model, Funnel Music supports the long-term development of artists while minimizing financial burdens. The platform serves as a resource for aspiring musicians, offering expert guidance and mentorship to enhance their careers in the competitive music industry. Through this approach, Funnel Music aims to empower artists and streamline the process of recording and releasing music.

Fen EP Limited is a biomedical device company focused on preventing sudden cardiac death. The company specializes in invasive cardiac electrophysiology instrumentation, which is developed from academic research on paced electrogram fractionation analysis. This innovative technology enables healthcare professionals to predict the risk of sudden cardiac death, allowing for timely intervention and improved patient outcomes. Fen EP's commitment to advancing medical technology aims to enhance the safety and effectiveness of cardiac care.

Pronec Ltd seeks to develop a new class of cancer therapy that causes tumours to simply die, using proprietary peptides. The Company has identified a lead candidate molecule that causes necrosis of a wide range of tumour cell lines in culture, but does not affect normal cell lines. Cancer cell necrosis refers to death of cancer cells within a tumour. This new class of compounds is protected by GB and international patent applications.

Elucid mHealth Limited is a medication technology company based in Manchester, United Kingdom, established in 2013. The company specializes in developing adherence monitoring tools and a virtual health platform designed to enhance the efficiency of clinical trials. Its flagship product, Pill Connect, enables trial organizers to access real-time data on medication adherence, helping to prevent missed doses and ensuring protocol compliance. The system facilitates engagement measurements and automated dose reconciliation, thereby improving overall clinical trial outcomes and patient adherence. Elucid mHealth is committed to leveraging innovative technology to support healthcare providers and enhance patient care.

Aurio Limited is a healthcare technology company that has developed a patentable core technology aimed at alleviating the symptoms of tinnitus, a condition characterized by the perception of sound when no external sound is present. The company's flagship product is a musical application that employs masking technology to direct soothing sounds specifically to the affected ear, helping users manage their tinnitus and improve their daily communication experiences. Aurio targets the significant global market of individuals living with tinnitus, estimated at around 10% of adults, particularly those aged over 60.

Glyconics Ltd. is a diagnostics company based in Cambridge, United Kingdom, that specializes in developing portable infrared spectroscopy devices for the diagnosis and monitoring of chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Founded in 2013, Glyconics has created a hand-held miniaturized device that allows patients to conduct tests at home by analyzing sputum samples for specific biomarkers associated with COPD. Utilizing Fourier transform infrared spectroscopy, the device identifies spectral waves to provide detailed insights into the composition of the samples, facilitating early detection and monitoring of exacerbations in patients with suspected respiratory diseases.

Sky Medical Technology Limited is a biomedical device company based in High Wycombe, United Kingdom, specializing in neuromuscular electro-stimulation medical devices. Founded in 2006, the company has developed innovative products such as the geko device, which stimulates the common peroneal nerve to enhance venous blood flow, and the firefly device, designed to aid professional athletes in muscle recovery by improving lower limb circulation. The company’s OnPulse™ technology represents a significant advancement in bioelectronic compression therapy, offering clinically proven solutions for preventing and treating various circulatory conditions, including life-threatening blood clots, post-surgical swelling, and non-healing wounds. Sky Medical Technology's products cater to a range of medical applications and are utilized by healthcare professionals, including surgeons, nurses, physiotherapists, and podiatrists, in both clinical practice and studies. The company distributes its devices internationally across multiple regions, including Asia, Europe, and North America.

Videregen Limited is a regenerative medicine company based in Liverpool, United Kingdom, founded in 2011 as a spin-out from the Northwick Park Institute of Medical Research. The company specializes in developing organ replacement products to tackle the persistent shortage of organs available for transplantation. Videregen’s innovative technology focuses on creating biological scaffolds from decellularized tissues, which are then seeded with a patient's own stem cells to produce bespoke organ replacements. This approach aims to ensure that the grafts are non-immunogenic and tailored to the individual patient's needs. Initially concentrating on trachea and bowel conditions, Videregen seeks to introduce the first commercially available organ replacements, potentially enhancing patient outcomes and reducing healthcare costs.

AlgaeCytes Limited is a biotechnology firm that specializes in the production of high-value Omega 3 fatty acids and bio-actives derived from freshwater algae. These Omega 3 fatty acids are crucial for various bodily functions, including blood clotting and brain cell membrane formation, and are linked to numerous health benefits, such as heart disease protection and potential therapeutic effects on conditions like cancer and autoimmune diseases. By utilizing algae, AlgaeCytes aims to provide health-promoting ingredients that cater to the healthcare, personal care, and nutraceutical markets, simultaneously addressing the global reliance on diminishing fish stocks for protein and oil supplements. This approach not only enhances the availability of vegan and organic products but also contributes to more sustainable practices in health and wellness.

Sky Medical Technology Limited is a biomedical device company based in High Wycombe, United Kingdom, specializing in neuromuscular electro-stimulation medical devices. Founded in 2006, the company has developed innovative products such as the geko device, which stimulates the common peroneal nerve to enhance venous blood flow, and the firefly device, designed to aid professional athletes in muscle recovery by improving lower limb circulation. The company’s OnPulse™ technology represents a significant advancement in bioelectronic compression therapy, offering clinically proven solutions for preventing and treating various circulatory conditions, including life-threatening blood clots, post-surgical swelling, and non-healing wounds. Sky Medical Technology's products cater to a range of medical applications and are utilized by healthcare professionals, including surgeons, nurses, physiotherapists, and podiatrists, in both clinical practice and studies. The company distributes its devices internationally across multiple regions, including Asia, Europe, and North America.

Connect Childcare is a provider of nursery management software designed to enhance operational efficiency in childcare settings. The company's integrated software solutions assist nursery staff in managing administrative tasks such as assessments, progress reports, and planning, thereby reducing paperwork and allowing practitioners to focus more on child development. By streamlining these processes, Connect Childcare aims to improve the overall quality of care and support for children in nurseries globally.

Arterius Limited specializes in the development of an innovative bioresorbable coronary scaffold, commonly referred to as a stent. This next-generation polymer-based device is designed to dissolve over a period of 12 to 24 months, allowing it to be absorbed by the body without the need for surgical removal. By minimizing the frequency of surgeries and medical interventions, Arterius aims to enhance postoperative quality of life for patients. The company's scaffold offers similar ease of delivery as traditional bare metal and drug-eluting stents while also reducing acute platelet adherence and thrombus formation, thereby improving overall clinical outcomes.